Karela tablets contain bitter melon, a traditional botanical used for metabolic wellness. They are intended for adults seeking nutritional support for healthy blood glucose, weight management, and…
Karela tablets contain bitter melon, a traditional botanical used for metabolic wellness. They are intended for adults seeking nutritional support for healthy blood glucose, weight management, and normal liver function alongside balanced meals and prescribed care.
Bitter melon belongs to the cucurbit family. Its fruit contains several naturally occurring compounds, including charantin, polypeptide-p, and cucurbitane-type compounds. The product contains 60 tablets.
Karela tablets contain bitter melon, a traditional botanical used for metabolic wellness. They are intended for adults seeking nutritional support for healthy blood glucose, weight management, and normal liver function alongside balanced meals and prescribed care.
Karela is used as a supportive botanical for Weight Management and Blood Pressure, yet the strength of evidence differs between these outcomes.
Bitter melon belongs to the cucurbit family. Its fruit contains several naturally occurring compounds, including charantin, polypeptide-p, and cucurbitane-type compounds. Research has examined these constituents for possible effects on carbohydrate metabolism, insulin signalling, and glucose transport. Results remain mixed, and bitter melon should complement—not replace—diabetes treatment prescribed by a clinician.
The product contains 60 tablets.
Laboratory research suggests that bitter melon compounds may influence glucose uptake, glycogen formation, intestinal carbohydrate handling, and insulin-related signalling. Polypeptide-p has been studied for insulin-like activity, while charantin and related compounds have been examined for possible effects on glucose transport. These mechanisms may help explain why bitter melon has been used traditionally for glucose support.
A review in Complementary Therapies in Medicine found that clinical evidence for bitter melon in diabetes was limited and inconsistent, with study quality and preparation differences affecting the results [1].
The dose is decided individually, taking age, other medicines, and health conditions into account. Karela is supplied as tablets for oral use.
| Approach | Main mechanism or role | Main limitation |
|---|---|---|
| Karela botanical tablets | Bitter melon compounds may influence glucose-related pathways | Extract strength and clinical response can vary |
| Food-based fibre pattern | Slows carbohydrate absorption and supports satiety | Requires regular dietary changes |
| Prescription glucose-lowering treatment | Uses defined pharmacological mechanisms and monitored dosing | Can cause specific adverse effects and requires clinical supervision |
A prescription treatment has a defined active substance, studied dose range, and monitoring plan. Karela has a different role: it may support a broader lifestyle programme, but it does not provide a substitute for treatment of diagnosed diabetes.
The product should not be used to self-treat diabetic ketoacidosis, severe hyperglycaemia, jaundice, or unexplained weight loss. These symptoms require clinical assessment.
Use extra caution with insulin, sulfonylureas, meglitinides, and other glucose-lowering treatment. Combining several glucose-lowering approaches may produce symptoms of hypoglycaemia. Blood-pressure medicines also warrant monitoring if dizziness or faintness develops.
Karela is often tolerated when used in an appropriate amount, though digestive symptoms can occur. Bitter melon may cause abdominal discomfort, nausea, diarrhoea, constipation, or a bitter aftertaste. Allergic reactions are possible in people sensitive to plants in the Cucurbitaceae family.
The most relevant risk is an excessive fall in Blood Glucose Levels when Karela is combined with insulin or glucose-lowering medicines. Symptoms can include sweating, trembling, hunger, palpitations, blurred vision, confusion, weakness, and fainting.
Stop using the product and seek urgent medical help for facial swelling, breathing difficulty, widespread hives, severe vomiting, loss of consciousness, seizure, or confusion that does not improve after appropriate glucose treatment.
A patient may mistake a mild bitter aftertaste for an allergy. Allergy more often involves itching, hives, swelling, wheezing, or throat tightness.
In clinical practice, physicians usually assess Karela as an adjunct to nutrition and glucose monitoring rather than as a replacement for diabetes therapy. The American Diabetes Association describes lifestyle measures and evidence-based glucose-lowering medicines as core parts of diabetes care, with supplements requiring careful review because product composition and clinical evidence can vary [2]. Evidence remains limited. Product quality varies. Monitoring remains necessary.
A doctor will usually ask about insulin, diabetes tablets, blood-pressure treatment, anticoagulants, pregnancy, kidney function, liver function, and previous episodes of low glucose. The same tablet may be tolerated by one adult and unsuitable for another because the surrounding treatment plan differs.
One practical point often missed is that glucose improvement after a supplement may result from several simultaneous changes, such as smaller portions, more walking, or fewer sweet drinks. A single reading cannot establish that Karela caused the change.
The product also has limits. It does not provide a replacement for HbA1c testing, retinal screening, kidney monitoring, or foot care in diabetes.
Karela may add to the glucose-lowering effect of insulin, sulfonylureas, and other diabetes medicines. The American Diabetes Association’s 2025 Standards of Care support medication review when glucose readings or hypoglycaemia patterns change. Mineral supplements do not automatically make the combination safe, especially when they are part of a broader product containing glucose-lowering herbs. A clinician should review the complete list before combination use.
A single tablet does not have a reliably established duration of glucose-lowering action because preparations, extract strengths, and study methods differ. A 2012 review in Complementary Therapies in Medicine found insufficient consistency to define a precise duration for bitter melon preparations. Avoid taking another dose early because one reading remains high. Follow the individual dosing plan and monitor symptoms.
The preferred approach is to swallow Karela tablets with water unless a qualified clinician gives different instructions. The FDA's 2023 guidance explains that tablet splitting is appropriate only for certain formulations and should not be assumed for every product. Chewing can increase bitterness and may alter how a tablet is intended to be taken. Do not crush a tablet to mix into food without specific advice.
Yes, Karela may contribute to low blood sugar when combined with insulin or glucose-lowering medicines. WHO guidance on diabetes from 2023 identifies hypoglycaemia as a clinically significant risk associated with glucose-lowering treatment. Watch for sweating, shaking, hunger, palpitations, blurred vision, confusion, or faintness. Repeated symptoms require prompt review of the full treatment plan.
Keep the tablets dry, away from direct sunlight, and at a stable room temperature. The NHS's 2024 medicine-storage advice recommends keeping medicines away from heat, moisture, and children, which makes a cool, dry cupboard preferable to a bathroom shelf. During travel, keep the product in its original pharmacy container and avoid leaving it in a parked vehicle. Do not place tablets beside a kitchen sink or in checked luggage exposed to extreme temperatures.
Karela should not be given to children or adolescents unless a qualified clinician has specifically recommended it. The European Medicines Agency's 2024 paediatric guidance requires use in children to be supported by appropriate evidence for the product and indication. Children with abnormal glucose readings need assessment of the underlying cause rather than self-treatment with an adult botanical product. Parents should also avoid sharing their own diabetes supplements with a child.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
